Maharg60More data out on #EvuSheld ... and it is not pretty as COVID 2 mutates rapidly. So I have to confess that maybe #NHS were right after all. "The preliminary data indicate that Evusheld will no longer be effective against the following variants:
BA.4.6
BA.2.75.2
BQ.1
BQ.1.1
BF.7
XBB
These six variants together made up over 55% of cases nationwide as of November 4th."
https://cllsociety.org/2022/11/cll-societys-covid-19-update-for-the-week-of-november-7th-2022/
CLL Society’s COVID-19 Update for the Week of November 7th, 2022
Dr. Koffman interviewed the lead researcher, Dr. Carsten Niemann, Associate Professor of Hematology at the University of Copenhagen. Dr. Niemann shared encouraging news and a brighter outlook for those of us with CLL in this interview I hope you will enjoy.
JaxRafferty